Forcan 150

Quick links to important sections

Forcan 150

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Forcan 150

Property Description
Active ingredient Fluconazole
Form Oral capsule or tablet
Pharmacological class Azole Antifungal (Triazole derivative)
General purpose To inhibit the growth and spread of fungal infections
Origin Synthetic compound

Identity and Classification

Forcan 150 is a synthetic, prescription-only medicine whose active component is the substance Fluconazole, a molecule that has been clinically recognized for its selective action against fungal pathogens. This drug is classified as a systemically active antifungal agent, specifically belonging to the Triazole family, which distinguishes its application from antibiotics or antiviral compounds. Its inclusion on lists of essential medicines reflects its recognized effectiveness and role in global public health.

Composition and Form

The designation Forcan 150 mg refers to the composition of the oral solid dosage form, typically presented as a capsule or tablet designed for oral administration. The 150 mg value specifies the exact strength of the active substance, Fluconazole, contained within a single unit, which is critical for therapeutic consistency. The active ingredient is a white, crystalline powder that is combined with pharmaceutical excipients—inert components required to create the final, standardized preparation.

General Therapeutic Purpose

Fluconazole's core therapeutic purpose is to achieve control over fungal infections by inhibiting the growth and proliferation of sensitive fungal organisms throughout the body. This effect is accomplished by highly selective interference with the fungal metabolic pathway, acting primarily by blocking the synthesis of ergosterol, an essential component of the fungal cell membrane. Pharmacological studies confirm that this mechanism arrests the organism's ability to multiply, which provides the fundamental general benefit of containing the mycotic infection throughout the patient's system.

Regulatory References

  1. Fluconazole Mechanism of Action - NIH StatPearls

What side effects are possible with Forcan 150?

Possible Side Effects and Safety Information

The official safety profile for Fluconazole (Forcan 150 mg) is structured by government regulatory documents to classify the full spectrum of observed adverse reactions, from common to rare and serious events, based on clinical data and post-marketing surveillance. This information provides the official regulatory context for the drug's safety characteristics.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized by their expected incidence rate:

  • Very Common (ge 10%): Headache.
  • Common (1% to <10%): Nausea, abdominal pain, diarrhea, vomiting, and skin rash. These effects primarily involve Gastrointestinal Disorders and Nervous System Disorders.
  • Uncommon (0.1% to <1%): Reactions like dizziness, seizures, insomnia, and hypokalemia (a metabolic disorder) are documented.
  • Rare (0.01% to <0.1%): Includes effects such as tremor, certain signs of Hepatic Toxicity, and Torsades de pointes.

Documented Serious Adverse Reactions

Regulatory labeling highlights rare but clinically significant adverse reactions that involve major physiological systems:

  • Serious Hepatic Toxicity (including liver failure in rare cases).
  • Exfoliative Cutaneous Reactions (severe skin disorders like Stevens-Johnson Syndrome).
  • Cardiac Arrhythmias (including the risk of QT interval prolongation and Torsades de pointes).
  • Anaphylaxis (a rare severe allergic reaction).

Population-Specific Safety Considerations

The label notes specific cautions for certain populations. Elderly patients often have reduced renal function, which can alter drug disposition. Caution is also required for patients with pre-existing liver or renal dysfunction and those with proarrhythmic conditions (e.g., advanced cardiac failure or hypokalemia) due to increased risk of cardiac events. The regulatory text also identifies Immunocompromised Patients as potentially more prone to severe cutaneous reactions.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory framework for Fluconazole overdose is defined by the requirement to seek immediate medical attention when excessive exposure is suspected. All official information stems from human case reports and supporting data from high-dose animal studies.

Documented Overdose Manifestations Overdose has been officially reported to be associated with specific central nervous system (CNS) effects. These include documented human case reports of hallucination and episodes of paranoid behavior. Regulatory summaries also reference high-dose animal studies, which noted potentially serious outcomes such as decreased motility, reduced respiration, and the occurrence of clonic convulsions, sometimes preceding severe outcomes.

Emergency Management and Procedures In managing an overdose, the official regulatory stance is that no specific antidote is known for Fluconazole. This necessitates that clinical treatment must involve the prompt institution of symptomatic treatment supported by necessary medical measures. Procedural options listed in the official documents include the use of gastric lavage, when considered clinically appropriate by medical staff. Furthermore, regulatory pharmacokinetic data confirms that hemodialysis is effective for drug removal; a standard three-hour session is documented to reduce the plasma concentration of the active substance by approximately 50%. Continuous clinical observation is required following a suspected overdose.

Therapeutic Uses of Forcan 150

The therapeutic role of this medication generally involves addressing categories of fungal and yeast infections. Its uses generally span from localized to systemic conditions.


Addressing Discomfort from Mucosal and Genital Yeast Infections

This antifungal is commonly used to help manage conditions presenting with localized discomfort driven by Candida overgrowth on mucous membranes, which includes oral thrush, esophageal candidiasis, and recurrent vaginal yeast infections. By addressing the underlying fungal cause, it supports the easing of distressing manifestations, such as intense itching, burning, inflammation, and difficulty swallowing, which may assist with maintaining functional stability.

Controlling Systemic and Severe Fungal Diseases

It is relevant for easing the symptomatic burden of serious, invasive infections where the fungus may have spread to the bloodstream (candidemia) or deep organs. It is also commonly used to help with challenging symptomatic phases like cryptococcal meningitis. The primary therapeutic role is to help manage fungal growth throughout the patient’s system, which assists with supporting stability during acute phases.

Preventing Fungal Relapse in High-Risk Patients

It is commonly used as a prophylactic (preventive) measure for individuals with significantly weakened immune systems or as long-term suppressive therapy to help manage chronic conditions. This supports the patient during difficult episodes and may help patients cope more steadily with the risk of recurrence.


Quick Fact: Relief for Systemic and Mucosal Symptoms This medication is used for managing conditions that cause symptoms related to inflammatory or irritative states and provides supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Population Eligibility for Forcan 150

Use of this medicine is strictly governed by population-specific rules detailed in regulatory labeling, defining who is allowed to use it, who is restricted, and who must not use it.

Absolute Contraindications (Must Not Use):

Classification Rule
Allergy Status Known hypersensitivity to Fluconazole or related azole antifungal compounds.
Co-medication Concomitant use with specific drugs known to prolong the QT interval and metabolized by the CYP3A4 enzyme (e.g., Pimozide, Cisapride).
Metabolic Risk Hereditary problems of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption (for capsule form).

Conditional and Restricted Use:

  • Organ Function: Patients with hepatic dysfunction must use the medicine with caution and require close monitoring. Those with renal impairment (Creatinine Clearance le 50 mL/min) require dosage adjustments for multi-dose therapy.
  • Age Groups: Safety and efficacy for the genital candidiasis indication have not been established in the pediatric population. Neonates and infants also require specific, time-adjusted administration.
  • Reproductive Status: Use during pregnancy is generally not recommended/contraindicated unless for a life-threatening infection. Lactation is not advised during repeated or high-dose therapy. Women of child-bearing potential must use effective contraception during and shortly after high-dose treatment.

What should I know about interactions with other medicines?

The interaction profile for Forcan 150 (Fluconazole) is primarily defined by its documented effect as an inhibitor of drug-metabolizing enzymes. Regulatory information classifies the drug as a strong inhibitor of Cytochrome P450 2C9 ( CYP2C9) and CYP2C19, and a moderate inhibitor of CYP3A4. Co-administration with medicines processed by these enzyme systems typically results in increased plasma concentrations of the interacting substance.

Formal Restrictions and Contraindications

The regulatory labels state that co-administration is strictly contraindicated with certain medicines due to the risk of serious cardiotoxicity, including QTc prolongation. Prohibited combinations include, but are not limited to, Pimozide, Quinidine, and Erythromycin. The restriction for Terfenadine is formally specified for Fluconazole doses ge 400 mg per day.

Documented Exposure Modifications

Interacting Substance Official Interaction Outcome
Anticoagulants (e.g., Warfarin) Increases Prothrombin Time (PT).
Statins (e.g., Simvastatin) Increases Statins exposure.
Rifampin Reduces Fluconazole exposure ( AUC reduced by 25%).
Hydrochlorothiazide Increases Fluconazole plasma concentration (40%).

No mandatory timing requirements or administration separation rules are documented in the official labeling, and the drug's absorption is not clinically impaired by food. In patients with reduced renal function, the slower clearance of Fluconazole may heighten the potential severity of these documented interactions.

Mechanism of Action

Targeted Inhibition of Fungal Enzyme Systems

The action of Fluconazole focuses exclusively on the fungal enzyme Cytochrome P450 14alpha-demethylase (CYP51), which is necessary for the organism's metabolism. By acting as a selective inhibitor and binding to the enzyme's heme iron atom, the drug blocks a critical conversion step in the fungal sterol synthesis pathway. This initial molecular event governs the drug's downstream cellular effects.


Disruption of Cell Membrane Integrity

The enzyme inhibition initiates a mechanistic cascade that causes the crucial depletion of Ergosterol, the functional equivalent of cholesterol in human cells, and simultaneously leads to the accumulation of toxic sterol precursors. This dual cellular consequence destabilizes the fungal cell membrane, resulting in severe permeability and structural failure, which is the direct physiological change resulting in the arrest of the organism's growth and replication.


️ Understanding Mechanism Limitations and Resistance

The effectiveness of this inhibitory mechanism is physiologically constrained in certain fungal populations. These constraints arise when fungi alter the target enzyme structure (gene mutation) or actively reduce the drug concentration inside the cell by overexpressing efflux pumps. These limitations define the biological boundaries of the molecular interaction and influence the extent of the resultant growth arrest.

Dosage and Administration Information

Official Administration Guidelines

The use of Fluconazole (Forcan 150) is structured around established guidelines that define the administration, dosage, and scheduling patterns.

Approved Routes and Standard Regimens

The medicine is administered via two routes: oral (using capsules, tablets, or liquid suspension) and intravenous (IV) infusion. The oral and IV forms are considered therapeutically equivalent for systemic use.

Regimens vary by indication but often follow a standardized pattern. For certain acute conditions, a single oral dose of 150 mg is prescribed. For systemic or severe mucosal infections, a higher loading dose is administered on the first day, followed by a lower maintenance dose, typically taken once daily.

Procedural and Population Adjustments

The medicine may be taken with or without food, as its absorption is not clinically affected by meals. When administered intravenously, the solution must be given via a controlled slow infusion, generally not exceeding 200 mg per hour.

Specific dose adjustments are required for certain populations. The dose must be reduced in adult patients with impaired kidney function, with the adjustment calculated based on their creatinine clearance. Pediatric dosing is weight-based (mg/kg), and very young patients (neonates) require an extended dosing interval (e.g., every 48 or 72 hours) due to slower elimination rates.

Recent Clinical Evidence

Forcan 150: Recent Clinical Evidence

Evidence for Mucosal and Genital Yeast Infections

Research exploring conditions such as oral thrush and vaginal yeast infections was studied in short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies measured outcomes related to the visibility of signs and patient-reported outcomes describing perceived discomfort. While studies report how symptoms evolved in observed populations, there is limited information for long-term outcomes regarding the prevention of recurrence, and research is ongoing.

Evidence for Invasive and Systemic Fungal Diseases

This medicine was studied for use in systemic fungal infections, such as those involving the bloodstream or deep organs, primarily through RCTs and observational studies. Research examined patient survival rates and laboratory outcomes reflecting fungal clearance. Evidence is limited for comparison against newer antifungal options in critically ill patients, and findings were mixed in studies exploring initial treatment of infections caused by certain non-albicans Candida species.

Evidence for Cryptococcal Meningitis Management

This agent was evaluated in research exploring outcomes in patients with Cryptococcal Meningitis. Researchers utilized RCTs to investigate initial treatment versus long-term suppressive therapy used to prevent recurrence. Data show patterns related to fungal eradication rates, reporting that when used alone, this agent was associated with slower clearance from the cerebrospinal fluid (CSF) compared to combination treatments.

Long-Term Follow-up and Durability of Response

Long-term effects are not fully established regarding observed patterns related to fungal status over many years. Follow-up durations were limited in many initial efficacy trials, which primarily focused on acute clinical endpoints.

Evidence in Special Populations

This agent was observed in studies that included patient groups beyond healthy adults, such as those with underlying immune compromise and very low birth weight infants. However, data for certain groups remain insufficient, and the results apply only to the populations studied.

What Research Gaps and Uncertainties Remain

A key limitation is the lack of head-to-head comparative evidence against newer classes of systemic antifungal agents in all clinical situations. Furthermore, research documented that the emergence of reduced susceptibility was observed in some studies, and data are still emerging regarding certain long-term outcomes.

Frequently Asked Questions (FAQ)

Common questions about Forcan 150 (FAQ)

Q: How fast does Forcan 150 start working for thrush?

Clinical studies and official information suggest that some patients may begin to experience improvement in symptoms within the first few days of treatment with fluconazole. Regulatory patient information advises that it is important to take the medicine for the full duration prescribed to help ensure the infection is managed.

Q: Is it normal to feel a little nauseous after taking Forcan 150?

Regulatory safety information indicates that nausea is documented as a commonly reported side effect of this medicine. Other common effects reported in the official safety profile often involve gastrointestinal issues, such as abdominal pain and diarrhea.

Q: How long does Forcan 150 stay in your system?

According to the official product information, the fluconazole component has a long half-life (approximately 30 hours). Due to its half-life, the medicine can take an extended period for the full amount to be eliminated from the body after the final dose.

Q: Can I use Forcan 150 while breastfeeding (if prescribed)?

The manufacturer’s label advises that breastfeeding is generally not recommended if a patient is taking a repeated or high-dose regimen of this medicine. Information regarding the use of fluconazole while nursing should be reviewed with a healthcare provider.

Q: Is Forcan 150 safe for elderly patients?

Official regulatory information advises caution when fluconazole is used in elderly patients. This is because reduced kidney function in older adults can slow the removal of the medicine from the body, a factor that requires evaluation by a healthcare provider.

Q: Do you need to finish the whole course of Forcan 150 even if you feel better?

Official patient information often advises patients to continue with the full treatment time prescribed by their healthcare provider. Completing the prescribed regimen is generally recommended to help manage the infection and reduce the potential for recurrence.

Q: Does Forcan 150 affect birth control pills?

Studies included in the regulatory documentation show that fluconazole may cause small, statistically significant increases in the blood levels of certain hormones found in oral contraceptives. Women using hormonal birth control are advised to review this potential interaction with their healthcare provider.

Q: What happens if I miss a dose of Forcan 150?

Patient information provides specific guidance on what to do when a dose is missed during a multi-dose regimen. This information includes instructions on whether to take a forgotten dose or to skip it, and should be reviewed with the prescribing doctor.

Q: Are there any specific foods to avoid when taking Forcan 150?

No specific foods are mandated for avoidance according to official labeling. The medicine can be taken with or without food because its absorption is not clinically affected by meals.

Q: Why do some people need more than one tablet of Forcan 150?

The required dose and duration of treatment vary significantly based on the type and severity of the fungal infection being treated. While a single 150 mg dose may be used for a common infection, systemic (whole-body) infections and others require multi-day courses.

Q: Can I take ibuprofen or Tylenol with Forcan 150?

Fluconazole may increase the blood concentration of certain Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen, which is a factor that should be evaluated by a healthcare provider. Acetaminophen (Tylenol) is not specifically addressed in the regulatory labeling regarding drug interactions.

Q: What's the difference between Forcan 150 and other antifungal creams?

Forcan 150 (Fluconazole) is an oral systemic antifungal agent, meaning it is absorbed into the bloodstream and works throughout the body. Antifungal creams are topical treatments that only affect the local area where they are applied.

Q: Does Forcan 150 cause dizziness or drowsiness?

Dizziness is documented as an uncommon side effect in the regulatory product information. Official patient information advises that if a patient experiences dizziness or lightheadedness, activities like driving or operating machinery should be avoided.

Q: Are there any natural remedies that interact with Forcan 150?

Official patient information suggests reviewing the use of all complementary medicines, herbal remedies, and supplements with a healthcare provider. There is generally not enough regulatory information available to confirm the safety of all potential combinations.

Q: Can Forcan 150 be used for fungal nail infections?

According to the official product label, fungal nail infections (onychomycosis) are not one of the FDA-approved indications for this medicine. Healthcare providers may use it off-label, but this use is not covered by the primary regulatory approval.

Q: Does Forcan 150 interact with anxiety medications or SSRIs?

Fluconazole can inhibit certain liver enzymes (CYP450 enzymes) that are responsible for processing many other medicines, including some used for anxiety or depression (SSRIs). It is important for patients to review all prescription and non-prescription medicines with their healthcare provider due to the potential for interactions.

Q: Can Forcan 150 be taken at the same time as antacids?

Regulatory studies have shown that taking common aluminum/magnesium antacids immediately before fluconazole does not have a clinically significant effect on the absorption or elimination of fluconazole.

Q: Why do doctors often prescribe Forcan 150 for systemic fungal infections?

Fluconazole is a potent systemic antifungal agent that is indicated and approved for treating certain severe infections, including those involving the bloodstream (candidemia) and deep-seated organs. This is due to its verified effectiveness against common fungal pathogens.

Q: Does Forcan 150 make you more sensitive to the sun?

Patient information often includes guidance to avoid prolonged exposure to direct sunlight, sunlamps, or tanning beds while undergoing treatment with this medicine.

Q: Can children or teenagers take Forcan 150?

Yes, fluconazole is approved for use in pediatric patients, although the dosage is always determined based on the child's body weight. The official label notes that the efficacy for treating genital candidiasis has not been established for this patient population.

Q: Are there any long-term effects of taking Forcan 150 repeatedly?

Official information notes that long-term follow-up data from initial efficacy trials is limited. For patients on prolonged therapy, the regulatory label indicates that periodic evaluation of liver function may be part of standard care.

Q: Can Forcan 150 be used to prevent fungal infections?

Yes, fluconazole is officially indicated for prophylaxis (prevention) of fungal infections in certain high-risk patient groups, such as those who have compromised immune systems or are undergoing procedures like bone marrow transplants.

Q: Why is the dosage sometimes different for skin vs. vaginal infections?

The required dose and duration of therapy are specific to the type and location of the infection. Official prescribing information outlines different dosage regimens for localized infections, such as a single oral dose, versus multi-day or higher-dose regimens for other types of infections.

Q: Is Forcan 150 effective against all types of fungus?

No, fluconazole is only active against specific types of fungal organisms, such as Candida species and Cryptococcus neoformans. The official microbiology information notes that certain fungal strains may be considered resistant to this medicine.

Q: Does taking Forcan 150 require any special monitoring or blood tests?

For patients who have pre-existing liver conditions or who are receiving long-term treatment, the regulatory label states that periodic monitoring of liver function (blood tests) may be required.

Q: Can I take vitamins or mineral supplements while on Forcan 150?

Official patient information suggests reviewing the use of all vitamins, minerals, and supplements with a healthcare provider before beginning treatment with fluconazole.

Q: Is it better to take Forcan 150 in the morning or evening?

The medicine can be taken at any time of day, as its absorption into the body is not affected by food. While consistency is often encouraged for any medication, regulatory information states the medicine can be taken at any time of day.

How should Forcan 150 be stored and disposed of?

How to Store and Dispose of Forcan 150?

Forcan 150 (Fluconazole) must be stored and disposed of according to official regulatory requirements to maintain product stability and protect the environment.


Storage Conditions

Requirement Official Regulatory Mandate
Temperature Store at controlled room temperature, below 30°C (86°F).
Protection Protect from direct sunlight, excessive heat, and moisture.
Packaging Keep the medicine in its original container, tightly closed.

Disposal and Safety

  • Child Safety: Keep this medicine strictly out of the sight and reach of children.
  • Disposal: Do not throw away unused or expired medicine via household waste or wastewater.
  • Procedure: Disposal should be managed by returning the product to a pharmacist or through an approved drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Forcan 150 found in:

A-Z Index: